The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis
Conclusions There was no clear and consistent association between intervention-induced LVM change and mortality. Evidence for LVM as a valid surrogate end point in CKD is currently lacking.
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Isosorbide Mononitrate | Study | Urology & Nephrology